Clarithromycin tablet orange peel book information

This orange peel book database is jointly produced by yaozhi.com and tonghuayi.com Drug name: Clarithromycin tablet specification: 0.125g/0.25g the active ingredient clarithromycin of abbvie in the original research of this dosage form The binding of 50S subunit can inhibit the synthesis of protein and produce bacteriostatic effect Compared with erythromycin, it has good acid stability and certain activity to erythromycin resistant bacteria Clarithromycin can be combined with amoxicillin / metronidazole and a proton pump inhibitor to form a quadruple therapy to cure Helicobacter pylori This product was originally developed by abbvie In 1991, its product named biaxin was listed in the United States In Japan, Taisho's 50mg and 200mg tablets were used as reference In Europe, Belgium, Finland and other countries, this product was listed through MRP procedures In 1996, Xi'an Lijun Pharmaceutical Co., Ltd listed and sold the product in China At present, the domestic approval of the product includes two specifications of 0.125g and 0.25g According to the selection principle of national reference preparation, biaxin listed in the United States by abbvie is recommended as the reference preparation BCS classification (U.S.) drug name BCS classification trademark file clarithromycin 4 biaxin NICHD and the BCS classification (2011) summarized by the U.S Food and drug administration PDF domestic import situation import product category import reference situation there are non original research drug U.S reference drug name trademark reference holding company reference listing country clarithromycin tablets Biaxin abbvie US domestic approval document (see more) (46) drug name approval document No specification manufacturer approval time clarithromycin tablet Guoyao Zhun Zi h20033044 0.25g Shanghai Abbott Pharmaceutical Co., Ltd 2014-08-07 clarithromycin tablet Guoyao Zhun Zi h20033443 0.25g Guoyao group Jingfang (Anhui) Pharmaceutical Co., Ltd 2015-10-28 clarithromycin tablet Guoyao Zhun Zi H20033513 0.25g in accordance with c38h69no13 Jiangxi Huiren Pharmaceutical Co., Ltd June 30, 2015 clarithromycin tablet Guoyao Zhuzi h20043283 0.25g shanxijin huahuixing Pharmaceutical Co., Ltd August 31, 2015 clarithromycin tablet Guoyao Zhuzi h20055408 0.25g (calculated by c38h69no13) Chongqing kangkel Pharmaceutical Co., Ltd may 07, 2015 clarithromycin tablet Guoyao Zhuzi h10970023 0.125g Yueyang Tonglian Pharmaceutical Co., Ltd June 15, 2015 Guoyao Zhuzi of clarithromycin tablets h10970022 0.25g Yueyang Tonglian Pharmaceutical Co., Ltd August 31, 2015 Guoyao Zhuzi of clarithromycin tablets h20000222 0.125g Jiangsu Hengrui Pharmaceutical Co., Ltd September 15, 2015 Guoyao Zhuzi of clarithromycin tablets h10970033 50mg Jiangsu Hengrui Pharmaceutical Co., Ltd September 15, 2015 Guoyao Zhuzi of clarithromycin tablets H19990225 0.25g (based on c38h69no13) reference and filing information of extended information of Shandong Xinhua Pharmaceutical Co., Ltd on March 20, 2015 (28) basic information of drugs (1) dissolution information of the United States (5) listing information of the United States (44) drug registration information (106) bid winning information of drugs (1177) Chinese drug standard (27) foreign standard information (58) drug instruction information (6) Note: this orange peel book database is jointly produced by yaozhi.com and tonghuayi.com Data source: Orange Book Database